• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BET 结构域共调节因子与肥胖、炎症和癌症。

BET domain co-regulators in obesity, inflammation and cancer.

机构信息

Cancer Research Center, Nutrition Obesity Research Center, Departments of Medicine and Pharmacology, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118, USA.

出版信息

Nat Rev Cancer. 2012 Jun 22;12(7):465-77. doi: 10.1038/nrc3256.

DOI:10.1038/nrc3256
PMID:22722403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3934568/
Abstract

The bromodomain is a highly conserved motif of 110 amino acids that is bundled into four anti-parallel α-helices and found in proteins that interact with chromatin, such as transcription factors, histone acetylases and nucleosome remodelling complexes. Bromodomain proteins are chromatin 'readers'; they recruit chromatin-regulating enzymes, including 'writers' and 'erasers' of histone modification, to target promoters and to regulate gene expression. Conventional wisdom held that complexes involved in chromatin dynamics are not 'druggable' targets. However, small molecules that inhibit bromodomain and extraterminal (BET) proteins have been described. We examine these developments and discuss the implications for small molecule epigenetic targeting of chromatin networks in cancer.

摘要

溴结构域是一个高度保守的 110 个氨基酸的基序,折叠成四个反平行的α-螺旋,存在于与染色质相互作用的蛋白质中,如转录因子、组蛋白乙酰转移酶和核小体重塑复合物。溴结构域蛋白是染色质的“读取器”;它们招募染色质调节酶,包括组蛋白修饰的“书写器”和“橡皮擦”,以靶向启动子并调节基因表达。传统观点认为,参与染色质动力学的复合物不是“可成药”的靶标。然而,已经描述了抑制溴结构域和末端(BET)蛋白的小分子。我们检查了这些进展,并讨论了它们对癌症中小分子表观遗传靶向染色质网络的影响。

相似文献

1
BET domain co-regulators in obesity, inflammation and cancer.BET 结构域共调节因子与肥胖、炎症和癌症。
Nat Rev Cancer. 2012 Jun 22;12(7):465-77. doi: 10.1038/nrc3256.
2
Bromodomain inhibitors and cancer therapy: From structures to applications.溴结构域抑制剂与癌症治疗:从结构到应用
Epigenetics. 2017 May 4;12(5):323-339. doi: 10.1080/15592294.2016.1265710. Epub 2016 Dec 2.
3
You bet-cha: a novel family of transcriptional regulators.没错:一类新型转录调节因子家族。
Front Biosci. 2001 Aug 1;6:D1008-18. doi: 10.2741/florence.
4
The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins.溴结构域与额外末端结构域(BET)家族:BET 旁系同源蛋白的功能剖析
Int J Mol Sci. 2016 Nov 7;17(11):1849. doi: 10.3390/ijms17111849.
5
A mechanism for epigenetic control of DNA replication.一种用于 DNA 复制的表观遗传控制机制。
Genes Dev. 2018 Feb 1;32(3-4):224-229. doi: 10.1101/gad.306464.117. Epub 2018 Feb 26.
6
Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.溴结构域和末端外结构域染色质调节剂可作为小鼠白血病病毒整合的辅助因子。
J Virol. 2013 Dec;87(23):12721-36. doi: 10.1128/JVI.01942-13. Epub 2013 Sep 18.
7
BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.BET溴结构域蛋白与炎症的表观遗传调控:对2型糖尿病和乳腺癌的影响
Cell Mol Life Sci. 2017 Jan;74(2):231-243. doi: 10.1007/s00018-016-2320-0. Epub 2016 Aug 4.
8
BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications.BET 溴结构域抑制剂:新颖的设计策略和治疗应用。
Molecules. 2023 Mar 29;28(7):3043. doi: 10.3390/molecules28073043.
9
Emerging roles of and therapeutic strategies targeting BRD4 in cancer.BRD4 在癌症中的新兴作用和治疗靶点。
Cell Immunol. 2019 Mar;337:48-53. doi: 10.1016/j.cellimm.2019.02.001. Epub 2019 Feb 4.
10
Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1.含溴结构域和额外末端(BET)结构域蛋白抑制剂JQ-1对肿瘤转化的表观遗传阻断作用
Biochem Pharmacol. 2016 Oct 1;117:35-45. doi: 10.1016/j.bcp.2016.08.009. Epub 2016 Aug 9.

引用本文的文献

1
NLRP3 inflammasome-driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitors.NLRP3炎性小体驱动的噬血细胞性淋巴组织细胞增生症的发生独立于白细胞介素-1β和白细胞介素-18,且可被溴结构域和额外末端结构域(BET)抑制剂靶向作用。
Sci Adv. 2025 Jul 11;11(28):eadv0079. doi: 10.1126/sciadv.adv0079. Epub 2025 Jul 9.
2
Challenges and opportunities for the diverse substrates of SPOP E3 ubiquitin ligase in cancer.SPOP E3泛素连接酶的多种底物在癌症中的挑战与机遇
Theranostics. 2025 May 8;15(13):6111-6145. doi: 10.7150/thno.113356. eCollection 2025.
3
Bromodomain and extraterminal protein inhibitor JQ1 induces maturation arrest and disrupts the cytoplasmic organization in mouse oocytes under in vitro conditions.溴结构域和额外末端蛋白抑制剂JQ1在体外条件下诱导小鼠卵母细胞成熟停滞并破坏其细胞质组织。
Sci Rep. 2025 Apr 18;15(1):13448. doi: 10.1038/s41598-025-96687-z.
4
Orally Bioavailable BRD4 BD1 Inhibitor ZL0516 Effectively Suppresses Colonic Inflammation in Animal Models of Inflammatory Bowel Disease.口服生物可利用的BRD4 BD1抑制剂ZL0516有效抑制炎症性肠病动物模型中的结肠炎症。
ACS Pharmacol Transl Sci. 2025 Apr 1;8(4):1152-1167. doi: 10.1021/acsptsci.5c00068. eCollection 2025 Apr 11.
5
Targeting FOXP1 phase separation in small cell lung cancer mechanisms of chemotherapy resistance.靶向小细胞肺癌化疗耐药机制中的FOXP1相分离
Commun Biol. 2025 Mar 13;8(1):431. doi: 10.1038/s42003-025-07804-7.
6
Role of IL-34 in Tumors and Its Application to Regulate Inflammation.白细胞介素-34在肿瘤中的作用及其在调节炎症中的应用
Cancer Sci. 2025 May;116(5):1164-1170. doi: 10.1111/cas.70020. Epub 2025 Feb 14.
7
Advancements in PROTAC-based therapies for neurodegenerative diseases.基于PROTAC的神经退行性疾病治疗方法的进展。
Future Med Chem. 2025 Mar;17(5):591-605. doi: 10.1080/17568919.2025.2463310. Epub 2025 Feb 11.
8
Epigenetic Mechanisms in the Transcriptional Regulation of Circadian Rhythm in Mammals.哺乳动物昼夜节律转录调控中的表观遗传机制。
Biology (Basel). 2025 Jan 8;14(1):42. doi: 10.3390/biology14010042.
9
A novel ROR1-targeting antibody-PROTAC conjugate promotes BRD4 degradation for solid tumor treatment.一种新型的靶向ROR1的抗体-PROTAC偶联物可促进BRD4降解用于实体瘤治疗。
Theranostics. 2025 Jan 1;15(4):1238-1254. doi: 10.7150/thno.102531. eCollection 2025.
10
BET inhibitor JQ1 induces apoptosis of ovarian and endometrial endometrioid carcinoma cells by downregulating .BET抑制剂JQ1通过下调……诱导卵巢和子宫内膜样癌细胞凋亡。
Oncol Lett. 2024 Dec 19;29(3):106. doi: 10.3892/ol.2024.14852. eCollection 2025 Mar.

本文引用的文献

1
BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.BRD4 是一种非典型激酶,可使 RNA 聚合酶 II C 端结构域丝氨酸 2 磷酸化。
Proc Natl Acad Sci U S A. 2012 May 1;109(18):6927-32. doi: 10.1073/pnas.1120422109. Epub 2012 Apr 16.
2
Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure.溴结构域蛋白 Brd4 与乙酰化染色质相关,对于维持高级染色质结构很重要。
J Biol Chem. 2012 Mar 30;287(14):10738-52. doi: 10.1074/jbc.M111.323493. Epub 2012 Feb 10.
3
Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.基于片段的溴结构域抑制剂发现 第 2 部分:苯并异恶唑磺酰胺的优化。
J Med Chem. 2012 Jan 26;55(2):587-96. doi: 10.1021/jm201283q. Epub 2012 Jan 11.
4
Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery.基于片段的溴结构域抑制剂发现 第 1 部分:抑制剂结合模式及其对先导化合物发现的意义。
J Med Chem. 2012 Jan 26;55(2):576-86. doi: 10.1021/jm201320w. Epub 2012 Jan 11.
5
RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus.RNA 聚合酶 II stalling 促进核小体封闭和 pTEFb 募集,从而驱动 Epstein-Barr 病毒的永生化。
PLoS Pathog. 2011 Oct;7(10):e1002334. doi: 10.1371/journal.ppat.1002334. Epub 2011 Oct 27.
6
Pathogenesis of NUT midline carcinoma.NUT 中线癌的发病机制。
Annu Rev Pathol. 2012;7:247-65. doi: 10.1146/annurev-pathol-011811-132438. Epub 2011 Oct 17.
7
Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation.基因标记加速有丝分裂后转录重新激活的动力学。
Nat Cell Biol. 2011 Oct 9;13(11):1295-304. doi: 10.1038/ncb2341.
8
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.抑制 BET 募集到染色质可作为治疗 MLL 融合白血病的有效方法。
Nature. 2011 Oct 2;478(7370):529-33. doi: 10.1038/nature10509.
9
Targeting MYC dependence in cancer by inhibiting BET bromodomains.通过抑制 BET 溴结构域靶向癌症中的 MYC 依赖性。
Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16669-74. doi: 10.1073/pnas.1108190108. Epub 2011 Sep 26.
10
Bromodomains as therapeutic targets.溴结构域作为治疗靶点。
Expert Rev Mol Med. 2011 Sep 13;13:e29. doi: 10.1017/S1462399411001992.